SAN DIEGO & COPENHAGEN, Denmark--(BUSINESS WIRE)--AFYX Therapeutics (“AFYX”), a clinical-stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, announced results ...
Oral findings are usually limited to type 1 diabetes. Problems include periodontal disease, delayed wound healing, and an increased risk of infection. Enlargement of the parotid glands may also be ...
SAN DIEGO & COPENHAGEN--(BUSINESS WIRE)--AFYX Therapeutics (“AFYX”), a clinical-stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, today announced Phase 2 ...
Oral melanoma is a rare cancer that forms in the mucosal tissues of the mouth. There may be no early symptoms, or a person may notice an area that is black or brown, with areas of gray, red, purple, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback